StacksVerified U.S. regulatory reference

21 CFR §349.1

Verified against eCFR.gov as of June 20, 2026View official text on eCFR.gov ↗
  1. (a)An over-the-counter ophthalmic drug product in a form suitable for topical administration is generally recognized as safe and effective and is not misbranded if it meets each of the conditions in this part and each of the general conditions established in § 330.1.
  2. (b)References in this part to regulatory sections of the Code of Federal Regulations are to chapter I of title 21 unless otherwise noted.